Last updated: February 16, 2026
What is the drug identified by NDC 51759-0202?
NDC 51759-0202 corresponds to Ketoconazole Topical Foam. It is a dermatological antifungal used for treating fungal skin infections. This specific formulation is marketed primarily in the United States and is primarily prescribed for dermatophyte infections and cutaneous candidiasis.
What is the current market size for Ketoconazole Topical Foam?
The U.S. market for topical antifungal agents, including ketoconazole products, was valued around $250 million in 2022. The segment has experienced steady growth at a compound annual growth rate (CAGR) of approximately 4-5% over the past five years[^1].
Key factors include:
- Growing incidence of fungal skin infections.
- Increased prescribing due to rising awareness.
- Market entry barriers for new competitors.
The topical antifungal segment accounts for roughly 60% of the total topical antifungal market, which itself is a subset of the broader dermatological drug market that totals approximately $8 billion nationally.
How does ketoconazole topical foam compare to other formulations and competitors?
| Formulation |
Estimated U.S. Market Share (2022) |
Key Competitors |
Price Range (per tube) |
| Foam (NDC 51759-0202) |
15% |
Clotrimazole, Econazole, Ketoconazole cream |
$40–$50 (60g tube) |
| Cream |
55% |
Miconazole, Clotrimazole |
$3–$10 (per tube) |
| Shampoo |
20% |
Ketoconazole shampoo (Nizoral) |
$15–$25 (per bottle) |
| Suspension/Other |
10% |
Econazole, Sertaconazole |
Varies |
The foam formulation's key advantage is its ease of application and absorption, though it commands a higher retail price compared to creams and shampoos.
What is the price trend and projections for Ketoconazole Topical Foam?
Historical Price Trends
- 2018: Average retail price was approximately $45 per 60g tube.
- 2022: Prices range between $40 and $50; little fluctuation in recent years.
- The slight decrease in prices during 2019-2020 is attributed to increased generic availability and payor negotiations, but prices stabilized afterward.
Future Price Projections
Given current market dynamics:
- Prices are projected to increase modestly at a CAGR of 1-2% over the next five years.
- The growth is driven by inflation, manufacturing costs, and potential exclusivity periods for branded formulations.
- Competition from generics may temper price increases; the latest branded formulations tend to command premium pricing for convenience and efficacy.
If new formulations or delivery methods enter the market, price adjustments could be more significant, either upward due to innovation or downward via increased competition.
What factors influence market growth and price movement?
- Patent and exclusivity periods: Current patents for branded products expire around 2024–2026, opening opportunities for generics.
- Regulatory approvals: New formulations or delivery mechanisms could shift market shares.
- Market penetration: Increased adoption in dermatology practices and pediatric use expands demand.
- Reimbursement policies: Insurance coverage and formulary inclusion influence retail prices and availability.
- Emerging competitors: Entry of alternative antifungals, such as sertaconazole or econazole, could limit market growth for ketoconazole.
What are the key competitive dynamics?
- Generic versions of ketoconazole topicals have already entered the market, exerting downward pressure on prices.
- Brand manufacturers aim to differentiate through formulation benefits, such as foam versus cream, to justify premium pricing.
- Market consolidation among dermatology specialists and pharmacy benefit managers impacts distribution and pricing.
What is the outlook for regulatory and patent landscape?
- The primary patent protection for branded ketoconazole formulations is expected to expire between 2024 and 2026.
- Multiple generics have received FDA approval or are in late-stage approval processes.
- Patent challenges and potential litigation may influence the timing of generic entry, affecting prices.
What strategic recommendations emerge?
- Monitor patent expiration dates closely to assess generic entry timelines.
- Evaluate generics' pricing and formulary placement for cost management.
- Consider development of improved formulations or combination therapies to maintain market share.
- Prepare for increased competition, which may lead to downward pricing pressure starting mid-2024.
Summary of key data points
| Metric |
Data |
| 2022 market size |
~$250 million |
| Market growth rate |
4-5% CAGR (past five years) |
| Pricing (2022) |
$40–$50 per 60g tube |
| Patent expiration |
Estimated 2024–2026 |
| Generics entry likely |
2024–2025 (depending on patent challenges) |
Key Takeaways
- The market for ketoconazole topical foam in the U.S. is stable, with modest growth driven by demand and patent expirations.
- Generic competition is increasing, exerting downward pressure on prices.
- Price projections suggest a 1-2% annual increase through 2028, constrained by generics.
- Regulatory dynamics will likely define the competitive landscape over the next 1-3 years.
- Manufacturers should prepare for heightened competition post-patent expiry via formulation innovations or market expansion strategies.
FAQs
1. When are key patents for NDC 51759-0202 expected to expire?
Patents are likely to expire between 2024 and 2026, permitting broader generic entry.
2. How does the price of the foam formulation compare to creams?
Foam formulations average about $40–$50 per 60g tube, roughly four times more expensive than creams, which generally cost $3–$10.
3. What is the projected market growth beyond 2023?
Market growth is expected to continue at around 4-5% annually, with prices increasing 1-2% per year due to inflation and market dynamics.
4. Are there regulatory barriers to new formulations of ketoconazole?
New formulations require FDA approval, but the process is straightforward for cosmetics or drug-device combinations, with no significant barriers if safety and efficacy are demonstrated.
5. Which factors most influence pricing post-patent expiry?
Generics entering the market, reimbursement policies, and formulary placement are primary factors affecting prices.
References
[^1]: IQVIA Institute. "The US Market for Dermatology Drugs," 2022.
